Single-shot versus multi-day palliative radiation for metastatic cancer
Treatments studied
Part of Cancer clinical trials.
This trial compares a single treatment session (one-fraction radiation) versus the usual multiple sessions (multi-fraction radiation) to help relieve symptoms from metastatic cancer. It may help your care team find the most effective and practical schedule for symptom control.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have metastatic (spread) cancer
- Your clinician recommends palliative radiation in 5 to 10 separate sessions
- Spinal cord compression is allowed (you can still join if you have it)
- You are willing and able to sign informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests higher doses of radiation therapy to relieve symptoms from larger tumors that cannot be cured. The goal is to improve symptom control and quality of life.
This trial tests a new radiation technique for people with cancer that has spread to bones or soft tissues in the chest, belly, or pelvis. The goal is to safely deliver effective palliative radiation to ease symptoms.
This Phase 2 study compares a one-time, high-dose radiation treatment (SBRT) with the usual, shorter-course palliative radiation. The goal is to see which approach better relieves symptoms from metastatic (spread) cancer.
This trial is testing whether a single radiation treatment to spine tumors works as well as multiple smaller treatments. It may be an option if you have cancer that has spread to up to 3 spots in your spine.
This trial tests a single session of radiation therapy to relieve pain and improve stability in up to two bone spots where cancer has spread. The goal is to make treatment faster and more convenient for patients.
This trial tests whether a precise type of radiation can control cancer that has spread to a limited number of sites (1–10) while you also have the main tumor. It aims to improve outcomes by treating all visible cancer spots with stereotactic ablative radiotherapy.
Hear when a new Palliative Radiotherapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.